Pharma Journalist 9038 posts 0 comments

HiFiBiO Therapeutics, a multinational biotherapeutics company with unique expertise in immune modulation and single cell science, announced a partnership with Russian pharmaceutical…
Read More...

Syngene International and Deerfield Discovery and Development Corporation (3DC), the drug discovery and development subsidiary of Deerfield Management Company (Deerfield), have signed…
Read More...

Be The Match BioTherapies, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Lonza announced a strategic partnership to…
Read More...

SMi Reports: SMi Group are delighted to announce that Julia Frese, Department Manager Centre of Combination Products, TÜV SÜD will be a speaker at the Pre-filled Syringes Europe…
Read More...

Novartis announced that it entered into an exclusive worldwide license and collaboration agreement with Mesoblast to develop, commercialize and manufacture remestemcel-L for the…
Read More...

RedHill Biopharma Ltd. a specialty biopharmaceutical company, today announced that it has initiated its Phase 3 study to evaluate the safety and efficacy of RHB-204 as a potential…
Read More...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for an additional dosing option, a 1,500mg fixed dose every four weeks, in the approved indications of unresectable Stage…
Read More...

Eli Lilly and Company and Incyte announced that the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the distribution and emergency use of…
Read More...

SMi Reports: There is only one to go to join the online webinar taking place on Thursday 26th November 2020 on Cost-efficient and Green Manufacturing of Peptides thanks to Molecular…
Read More...

Zymeworks Inc. announced that the European Commission (EC) has granted Orphan Drug designation for zanidatamab, the company’s investigational HER2-targeted bispecific antibody, in…
Read More...